PRODUCT OVERVIEW & COMPOSITION
Brand / Manufacturer: Bioniche Pharma
Active Ingredient: Trenbolone Enanthate (200 mg/ml)
Pharmacological Class: Synthetic $19\text{-Nortestosterone}$ Derivative / Long-Ester Anabolic-Androgenic Steroid
This single-entity injectable formulation by Bioniche Pharma contains Trenbolone Enanthate at a concentration of 200 mg/ml. Formulated as a long-acting esterified $19\text{-nor}$ compound, Trenbolone Enanthate is engineered by Bioniche Pharma to deliver sustained anabolic activity. It enhances protein metabolism, promotes optimal nitrogen retention, reverses catabolic tissue breakdown, and supports skeletal muscle accretion and strength development when combined with adequate dietary intake.
CLINICAL PHARMACOLOGY & MECHANISM OF ACTION
Trenbolone Enanthate exerts strong anabolic and androgenic actions by binding directly to intracellular androgen receptors. The molecule features an enanthate ester moiety that extends its pharmacokinetic release profile, making its action slower than Trenbolone Acetate while maintaining high intrinsic anabolic potency. It drives cellular protein synthesis, enhances nitrogen retention, and suppresses catabolic glucocorticoid activity. Like other trenbolone derivatives, it does not aromatize directly into estradiol, avoiding direct estrogenic conversion.
INDICATIONS & CLINICAL USE
- Anabolic therapy for promoting nitrogen retention, protein anabolism, and accelerated tissue regeneration.
- Reversal of catabolic muscle wasting and support of lean body mass accretion in debilitated states under medical supervision.
CONTRAINDICATIONS
- Male patients with known, suspected, or treated carcinoma of the prostate gland or male breast cancer.
- Female patients with breast carcinoma complicated by hypercalcemia (elevated serum calcium levels).
- Females who are pregnant or may become pregnant due to severe risks of fetal virilization, malformations, and endocrine toxicity. Women must strictly avoid this product under all circumstances.
- Patients with severe cardiac failure, advanced hepatic disease, or severe renal impairment.
- Patients with documented hypersensitivity or allergic reaction to Trenbolone Enanthate, carrier oils, or inactive components in Bioniche Pharma formulations.
ADVERSE REACTIONS & SPECIAL PRECAUTIONS
- Dermatological & Androgenic: Oily skin, severe acne vulgaris (commonly manifesting on the face, shoulders, upper arms, lower arms, chest, and back during initial therapy), and accelerated hair loss (androgenetic alopecia).
- Behavioral & CNS: Dose-dependent increases in aggressive behavior, irritability, and mood shifts, particularly at higher dosage levels.
- Organ System Surveillance: Cardiovascular, hepatic, and renal parameters should be regularly evaluated during therapy due to potential systemic strain associated with potent androgen administration.
- Endocrine Suppression: Severe, rapid suppression of the endogenous Hypothalamic-Pituitary-Testicular Axis (HPTA), leading to testicular atrophy and secondary hypogonadism.
DOSAGE & ADMINISTRATION
Bioniche Pharma Trenbolone Enanthate is formulated strictly for deep intramuscular injection. The extended release kinetics of the enanthate ester allow for less frequent dosing schedules compared to short-acting esters:
- Prescribed Dosage: The most common clinical dosage is 200 mg administered 1 to 2 times per week (200 mg to 400 mg total weekly dose) via intramuscular injection, titrated according to medical advice and individual tolerance.
- Restricted Populations: Strictly contraindicated for use in women, pediatric patients, and adolescents.
STORAGE & HANDLING
Store Bioniche Pharma injectable products in a cool, dry place protected from direct light exposure and excess heat. Do not refrigerate or freeze. Keep strictly out of reach and sight of children.